Performance Food Group insider sales disclosed in Form 144; 1,320 shares planned

Rhea-AI Filing Summary

Performance Food Group Company (PFGC) filing a Form 144 notifies the proposed sale of 1,320 common shares by an affiliated person through Morgan Stanley Smith Barney LLC, with an aggregate market value of $134,521.20. The sale is scheduled for 08/25/2025 on the NYSE. The shares were acquired on 08/22/2025 as restricted stock awards (RSA) from the issuer and paid for on that date.

The filing also discloses prior 10b5-1 sales by Erika T. Davis totaling 14,045 shares sold on 05/29/2025, 08/19/2025 and 08/20/2025 for combined gross proceeds reported in the filing.

Positive

• Compliance: The filer provides required Rule 144 details, including acquisition date, payment, and broker information, indicating procedural compliance
• Transparency: Prior 10b5-1 sales by the same insider are disclosed, offering visibility into recent insider transactions

Negative

• Insider selling: The filing notifies additional insider sales which some investors may view as negative sentiment, though the amounts appear small relative to outstanding shares

Insights

Securities Analyst

TL;DR: Insider sale notice for a modest block of shares, consistent with prior 10b5-1 activity; not clearly material to company fundamentals.

The Form 144 reports a proposed sale of 1,320 common shares valued at $134,521.20 to be executed through Morgan Stanley Smith Barney on the NYSE and acquired as RSAs on 08/22/2025. The filer also disclosed three recent 10b5-1 plan sales by Erika T. Davis totaling 14,045 shares with reported gross proceeds for each trade. From a market-impact perspective, the block size is small relative to the reported outstanding shares (156,519,106), suggesting limited direct effect on supply or liquidity. The repeated 10b5-1 sales indicate routine insider monetization rather than a single, unexpected disposition.

Corporate Governance Expert

TL;DR: Filing shows compliance with Rule 144 and disclosure of 10b5-1 sales; procedural adherence reduces regulatory risk.

The notice documents acquisition details, payment timing, and the seller's representation regarding material nonpublic information, consistent with regulatory requirements. The inclusion of acquisition date, nature (RSA), and the statement about 10b5-1 adoption or instructions addresses common disclosure expectations. No information in the filing suggests governance or disclosure lapses. As always, shareholders may review the volume and timing of insider sales alongside public disclosures for additional context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1320	134521.20	156519106	08/25/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	RSA	Issuer			1320	08/22/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/20/2025	4316	433836.98
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/19/2025	1529	152365.00
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	05/29/2025	8200	735680.22

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the PFGC Form 144 filed mean?

It notifies a proposed sale of 1,320 common shares of PFGC valued at $134,521.20, to be sold on 08/25/2025 through Morgan Stanley Smith Barney LLC.

Who is selling PFGC shares according to the filing?

The filing lists prior 10b5-1 sales by Erika T. Davis and the current proposed sale appears for the account of an affiliated person who acquired the shares as an RSA on 08/22/2025.

How many PFGC shares were outstanding per the filing?

The filing reports 156,519,106 shares outstanding for the issuer.

Were there recent insider sales for PFGC before this notice?

Yes. The filing discloses 10b5-1 sales by Erika T. Davis of 8,200, 4,316, and 1,529 shares on 05/29/2025, 08/20/2025, and 08/19/2025 respectively, with gross proceeds shown for each sale.

Where will the proposed sale be executed?

The proposed sale is scheduled to be executed on the NYSE via Morgan Stanley Smith Barney LLC.